Metabolism and Pharmacokinetics of Dexmedetomidine

Hepatic Metabolism and Pharmacokinetic Properties

• Dexmedetomidine is primarily metabolized in the liver to inactive metabolites through glucuronidation and hydroxylation processes 1
• Dexmedetomidine has a relatively short elimination half-life of approximately 1.8-3.1 hours in patients with normal liver function 2

Clinical Implications and Monitoring Considerations

• Patients with severe hepatic dysfunction have impaired dexmedetomidine clearance and may require lower doses 2, 3
• Due to its hepatic metabolism, liver function should be considered when dosing dexmedetomidine 3
• The drug's elimination may be prolonged in patients with hepatic impairment 3
• Continuous hemodynamic monitoring is essential during dexmedetomidine administration due to potential cardiovascular effects 2

Drug Interactions

• Concomitant use with other sedatives or CNS depressants may potentiate effects 2